Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 3Phase 1/2 3Phase 1 3Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 5Neoplasms 4Recurrence 3Prostatic Neoplasms 3Leukemia, Myeloid, Acute 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Respiratory Aspiration 2Myelodysplastic Syndromes 2Liver Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Postoperative Complications 1Postoperative Cognitive Complications 1Ovarian Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, B-Cell 1Lymphatic Metastasis 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Immunologic Deficiency Syndromes 1Hormone Refractory Prostate Cancer 1Head and Neck Neoplasms 1HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy 1Delirium 1

Interventions

Early Intervention, Educational 29Educational Status 28Blood Specimen Collection 28Standard of Care 26Methods 24Exercise 20Magnetic Resonance Spectroscopy 19Radiosurgery 18Surveys and Questionnaires 17Practice Guidelines as Topic 17X-Rays 16Tomography, X-Ray Computed 13Radiotherapy 11Biopsy 11Specimen Handling 10Interviews as Topic 10Fluorodeoxyglucose F18 10Patient Navigation 9Bronchoscopy 9Thoracic Surgery, Video-Assisted 8Therapeutics 8Saline Solution 7Psychiatric Rehabilitation 7Palliative Care 7Control Groups 7Acupuncture Therapy 7Drug Therapy 6Cryosurgery 6Counseling 6Breathing Exercises 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lung Neoplasms × Injections × Clear all
NCT05631028 2023-03-14

95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment

Shanghai Pulmonary Hospital, Shanghai, China

Phase NA Completed
115 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡